Beta-defensin 130B

Also known as: DEFB130B, P0DP73

**Mechanism of Action** Beta-defensin 130B (DEFB130B, UniProt P0DP73) is classified as an antimicrobial host-defense peptide, a member of the beta-defensin family. These peptides typically exert their effects by disrupting microbial cell membranes through electrostatic interactions with negatively charged phospholipids, leading to pore formation and cell lysis. Additionally, beta-defensins may modulate immune responses via chemotactic activity and cytokine regulation, though specific mechanistic details for DEFB130B remain uncharacterized due to limited experimental data. **Key Research Findings** No peer-reviewed studies indexed in PubMed currently exist for DEFB130B. Its identification is based on genomic and proteomic annotations, with predicted structural features common to beta-defensins, including a conserved six-cysteine motif forming three disulfide bridges. Functional validation, antimicrobial spectrum, and in vivo activity have not been experimentally established. The peptide remains in an experimental stage with no published preclinical or clinical data. **Clinical Relevance** Given the absence of research findings, DEFB130B has no established clinical relevance. Its potential as an antimicrobial agent or immunomodulator is speculative. Further studies are required to determine its biological activity, safety, and therapeutic applicability. For research purposes only — not medical advice.

Key data

Mechanism of action

Antimicrobial host-defense peptide. Has an antiplasmodial activity

Frequently asked questions

Related peptides